Combination Bacillus Calmette-Guérin and indoleamine 2,3-dioxygenase 1 inhibitor therapy of murine orthotopic bladder cancer

BJU Int. 2020 Nov;126(5):554-556. doi: 10.1111/bju.15201. Epub 2020 Aug 29.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetamides* / pharmacology
  • Acetamides* / therapeutic use
  • Animals
  • Antineoplastic Agents* / pharmacology
  • Antineoplastic Agents* / therapeutic use
  • BCG Vaccine* / pharmacology
  • BCG Vaccine* / therapeutic use
  • Indoleamine-Pyrrole 2,3,-Dioxygenase / antagonists & inhibitors*
  • Kynurenine / blood
  • Mice
  • Neoplasms, Experimental / chemistry
  • Neoplasms, Experimental / drug therapy
  • Quinolines* / pharmacology
  • Quinolines* / therapeutic use
  • Urinary Bladder / chemistry
  • Urinary Bladder / drug effects
  • Urinary Bladder Neoplasms* / chemistry
  • Urinary Bladder Neoplasms* / drug therapy

Substances

  • Acetamides
  • Antineoplastic Agents
  • BCG Vaccine
  • Indoleamine-Pyrrole 2,3,-Dioxygenase
  • Quinolines
  • linrodostat
  • Kynurenine